Investing Through the Regulatory Process: What to Expect in MedTech, Bio, and Diagnostics
Regulatory pathways are among the most critical—and least understood—factors shaping investment outcomes in MedTech, biotech, and diagnostics. For angel investors, especially those new to life‑science investing, regulatory strategy directly influences capital requirements, development timelines, valuation inflection points, and overall portfolio risk. This session offers a practical, investor‑centric perspective on how regulatory processes impact early‑stage life‑science ... Read more